Transform Your Weight Loss Journey with Advanced GLP-1 Therapy Safe, effective, and personalized weight management using the same active ingredient as FDA-approved semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro) treatments
Glutathione biosynthesis: -glutamylcysteine synthetase from rat kidney
2026 guidance implies 22% topline growth and $715M adjusted EBITDA
However, the enhanced weight loss from the combination could lead to more pronounced fluid and electrolyte shifts that indirectly affect heart rate and blood pressure
For clients focusing on weight management, Wegovy provides a higher dose of Semaglutide, promoting weight loss as part of a comprehensive lifestyle plan that includes nutritional guidance and physical activityservices we proudly offer
Many patients begin to see significant weight loss within the first month of treatment